Oriented co-continuous 3D porous scaffolds with inhibited activating functionality: An effective strategy to inhibit the hyperactivation of astrocytes
Source abstract
Abstract
Astrocyte activation is an important cause of neuropathic pain. Inhibiting the hyperactivation of astrocytes is beneficial to control over neuropathic pain. However, there is a lack of non-pharmaceutical ways to inhibit the hyperactivation of astrocytes. This study aimed at regulating the activity of glial cells via the architecture of 3D porous scaffolds. Herein, the 3D porous scaffolds with co-continuous and oriented pores were prepared via solid-phase stretching of co-continuous polymer blends followed by selective phase extraction. Compared to the isotropic scaffold, the proliferation of astrocytes slowed down on the oriented scaffolds. Meanwhile, the expression of growth factors and inflammatory factors secreted by astrocyte activation was inhibited by the oriented pores. It led to the suppression of the Wnt/β-catenin signaling pathway that is crucial to determine chronic neuropathic pain. Immunofluorescence staining displayed that the hyperactivation of astrocytes was inhibited, and the expression of kindlin-1, a key protein that activates astrocytes, was downregulated. The proposed strategy offers a probable physical means to relieve neuropathic pain.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Pain Mechanisms and Treatments · Nerve injury and regeneration · Botulinum Toxin and Related Neurological Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. The reciprocal associations between catastrophizing and pain outcomes in patients being treated for neuropathic pain: a cross-lagged panel analysis study10.1097/j.pain.0000000000000594 ↗
2. Prevalence of chronic pain with neuropathic characteristics in the general population10.1016/j.pain.2007.08.013 ↗
3. Driving effect of BDNF in the spinal dorsal horn on neuropathic pain10.1016/j.neulet.2021.135965 ↗
4. Systemic Injection of Thalidomide Prevent and Attenuate Neuropathic Pain and Alleviate Neuroinflammatory Response in the Spinal Dorsal Horn10.2147/JPR.S213112 ↗
5. S.K. Kim, H. Hayashi, T. Ishikawa, K. Shibata, E. Shigetomi, Y. Shinozaki, H. Inada, S.E. Roh, S.J. Kim, G. Lee, H. Bae, A.J. Moorhouse, K. Mikoshiba, Y. Fukazawa, S. Koizumi, J. Nabekura, Cortical astrocytes rewire somatosensory cortical circuits for peripheral neuropathic pain, J. Clin. Invest. 126 (2016) 1983–1997. DOI: 10.1172/JCI82859.10.1172/JCI82859 ↗
6. B.C. Jiang, D.L. Cao, X. Zhang, Z.J. Zhang, L.N. He, C.H. Li, W.W. Zhang, X.B. Wu, T. Berta, R.R. Ji, Y.J. Gao, CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5, J. Clin. Invest. 126 (2016) 745–761. DOI: 10.1172/JCI81950.10.1172/JCI81950 ↗
7. Pain regulation by non-neuronal cells and inflammation10.1126/science.aaf8924 ↗
8. Neuropathic Pain: From Mechanisms to Treatment10.1152/physrev.00045.2019 ↗
9. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain10.1016/j.pain.2005.05.004 ↗
10. Etiology and Pharmacology of Neuropathic Pain10.1124/pr.117.014399 ↗
11. Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain10.3389/fnins.2019.01268 ↗
12. Off-label Antidepressant Use for Treatment and Management of Chronic Pain: Evolving Understanding and Comprehensive Review10.1007/s11916-019-0803-z ↗
13. Use of anticonvulsants for treatment of neuropathic pain
14. B. Watterworth, T.B. Wright, Diabetic Peripheral Neuropathy, in: A. Abd-Elsayed (Ed.), Pain Rev. Guide, Springer International Publishing, Cham, 2019: pp. 911–913. DOI: 10.1007/978-3-319-99124-5_194.10.1007/978-3-319-99124-5_194 ↗
15. S.P. Cohen, J. Mao, Neuropathic pain: mechanisms and their clinical implications, BMJ 348 (2014) f7656. DOI: 10.1136/bmj.f7656.10.1136/bmj.f7656 ↗
16. The outcome of carpal tunnel decompression in patients with diabetes mellitus10.1302/0301-620X.94B6.29174 ↗
17. Analysis of the effect of probucol-mecobalamin tablets combination on oxidative stress in patients with diabetic peripheral neuropathy10.1016/j.neulet.2020.135484 ↗
18. Glia: victims or villains of the aging brain?10.1016/j.nbd.2020.105008 ↗
19. Astrocytic adenosine: from synapses to psychiatric disorders10.1098/rstb.2013.0594 ↗
20. 3D additive-manufactured nanocomposite magnetic scaffolds: Effect of the application mode of a time-dependent magnetic field on hMSCs behavior
21. Design and additive manufacturing of flexible polycaprolactone scaffolds with highly-tunable mechanical properties for soft tissue engineering10.1016/j.matdes.2020.108508 ↗
22. Design
23. 3D Printed Wavy Scaffolds Enhance Mesenchymal Stem Cell Osteogenesis10.3390/mi11010031 ↗
24. Nanofibrous ε-polycaprolactone scaffolds containing Ag-doped magnetite nanoparticles: Physicochemical characterization and biological testing for wound dressing applications in vitro and in vivo
25. Fabrication of tri-layered electrospun polycaprolactone mats with improved sustained drug release profile10.1038/s41598-020-74885-1 ↗
26. Electrohydrodynamic jet 3D-printed PCL/PAA conductive scaffolds with tunable biodegradability as nerve guide conduits (NGCs) for peripheral nerve injury repair10.1016/j.matdes.2018.11.044 ↗
27. Aligned PCL Fiber Conduits Immobilized with Nerve Growth Factor Gradients Enhance and Direct Sciatic Nerve Regeneration10.1002/adfm.202002610 ↗
28. Engineering anisotropic human stem cell-derived three-dimensional cardiac tissue on-a-chip10.1016/j.biomaterials.2020.120195 ↗
29. Construction of Biofunctionalized Anisotropic Hydrogel Micropatterns and Their Effect on Schwann Cell Behavior in Peripheral Nerve Regeneration10.1021/acsami.9b08510 ↗
30. Adhesion Anisotropy Substrate with Janus Micropillar Arrays Guides Cell Polarized Migration and Division Cycle10.1002/anie.201814579 ↗
31. Halloysite nanotubes coated 3D printed PLA pattern for guiding human mesenchymal stem cells (hMSCs) orientation10.1016/j.cej.2018.11.145 ↗
32. Uniaxial Tensile Deformation of Poly(ε-caprolactone) Studied with SAXS and WAXS Techniques Using Synchrotron Radiation10.1021/ma301714f ↗
33. Toward biomimetic porous poly(ε-caprolactone) scaffolds: Structural evolution and morphological control during solid phase extrusion10.1016/j.compscitech.2018.01.009 ↗
34. Antimicrobial polycaprolactone/polyethylene glycol embedded lysozyme coatings of Ti implants for osteoblast functional properties in tissue engineering10.1016/j.apsusc.2016.11.129 ↗
35. Highly aligned and interconnected porous poly(ε -caprolactone) scaffolds derived from co-continuous polymer blends10.1016/j.matdes.2017.05.004 ↗
36. Fabrication and characterization of porous polycaprolactone scaffold via extrusion-based cryogenic 3D printing for tissue engineering10.1016/j.matdes.2019.107946 ↗
37. The neuroprotective roles of BDNF in hypoxic ischemic brain injury10.3892/br.2012.48 ↗
38. Therapeutic Potential of Neurotrophins for Repair After Brain Injury: A Helping Hand From Biomaterials10.3389/fnins.2019.00790 ↗
39. BDNF in sensory neurons and chronic pain10.1016/j.neures.2006.01.005 ↗
40. BDNF: No gain without pain?10.1016/j.neuroscience.2014.05.044 ↗
41. Hyperalgesia due to nerve damage: role of nerve growth factor10.1016/S0304-3959(99)00018-4 ↗
42. Sensitization of glutamate receptor-mediated pain behaviour via nerve growth factor-dependent phosphorylation of transient receptor potential V1 under inflammatory conditions10.1111/bph.15176 ↗
43. Wnt/β-Catenin Signaling Triggers Neuron Reprogramming and Regeneration in the Mouse Retina10.1016/j.celrep.2013.06.015 ↗
44. Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice10.1016/j.bbrc.2012.03.006 ↗
45. Wnt Signaling Promotes Müller Cell Proliferation and Survival after Injury10.1167/iovs.12-10774 ↗
46. WNT signaling underlies the pathogenesis of neuropathic pain in rodents10.1172/JCI65364 ↗
47. The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation10.1016/j.biomaterials.2007.10.025 ↗